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Granulocyte-macrophage colony-stimulating factor
(GM-CSF) promotes dendritic cell (DC) differentiation
and survival in vitro. However, its role in host defense
at the intestinal mucosa is unknown. We report
that infection with the mouse enteric pathogen,
Citrobacter rodentium, increased colonic GM-CSF
production and CD11c+ DC recruitment. After infec-
tion, GM-CSF/ mice had fewer mucosal CD11c+
DCs, greater bacterial burden, increased mucosal
inflammation and systemic spread of infection,
decreased antibody responses, and delayed path-
ogen clearance. This defective mucosal response
was rescued by GM-CSF administration to GM-
CSF/mice and mimicked by CD11c+ DC depletion
in wild-type animals. Diminished mucosal DC num-
bers in infected GM-CSF/ mice reflected de-
creased DC recruitment and survival, with the
recruitment defect being related to a failure to upre-
gulate epithelial cell production of the DC chemoat-
tractant, CCL22. Thus, GM-CSF produced in the
intestinal mucosa acts to enhance host protection
against an enteric bacterial pathogen through regu-
lating recruitment and survival of DCs.
INTRODUCTION
Granulocyte-macrophage colony-stimulating factor (GM-CSF)
stimulates myeloid cell development and maturation (Hamilton
and Anderson, 2004) and promotes dendritic cell (DC) differenti-
ation and survival in vitro. It is used in cell culture to generate DC
from blood and bonemarrow (BM) precursors (Inaba et al., 1992;
Markowicz and Engleman, 1990). However, mice deficient in
GM-CSF (GM-CSF/) have normal numbers of BM DC progen-
itors andmature DCs in spleen, thymus, and lymph nodes, which
suggests a redundant role for GM-CSF in steady-state DCmain-
tenance (Dranoff et al., 1994; Stanley et al., 1994). GM-CSF/
mice have defective alveolar macrophage function and develop
a spontaneous pulmonary alveolar proteinosis-like phenotype
(Paine et al., 2000; Stanley et al., 1994). Consistent with this,Cell HostGM-CSF has been reported to activate alveolar macrophages
that can protect the host from respiratory pathogens (Dranoff
et al., 1994; LeVine et al., 1999; Shibata et al., 2001), and
GM-CSF/ mice are more susceptible to several respiratory
pathogens (Deepe et al., 1999; Gonzalez-Juarrero et al., 2005;
LeVine et al., 1999; Paine et al., 2000). However, the role of
GM-CSF in regulating host defenses in other mucosal organs
remains poorly understood. In particular, whether GM-CSF
has a physiological role in the intestinal tract, the most important
entry portal for microbial infections in mammals, with respect to
antimicrobial defense or DC functions is not known.
Enterohemorrhagic Escherichia coli (EHEC) and enteropatho-
genic E. coli (EPEC) are important causes of severe diarrhea
and death worldwide (Kaper et al., 2004). Such pathogens,
termed A/E pathogens, induce characteristic attaching-and-
effacing (A/E) lesions in the intestinal epithelium, which are
important for establishing infection in the host. Citrobacter
rodentium is a naturally occurring mouse pathogen that is
widely used to model infections with A/E pathogens in humans
(Borenshtein et al., 2008). In wild-type (WT) mice, C. rodentium
colonizes the apical surface of colon epithelial cells and effaces
the epithelial cell microvilli, but does not invade deeper layers of
the colon mucosa or spread systemically. Infection is charac-
terized by an inflammatory cell infiltrate in the colon lamina
propria and hyperplasia of the colonic crypts (Eckmann, 2006;
Maaser et al., 2004; Mundy et al., 2005). We previously reported
that CRAMP, an epithelial cell antimicrobial protein belonging to
the cathelicidin family, is important in determining early coloni-
zation of the host with C. rodentium (Iimura et al., 2005),
whereas CD4+ T cells, B cells, and IgG antibodies to C. roden-
tium are important in controlling infection in the later periods
and are required for ultimate pathogen clearance (Bry and
Brenner, 2004; Maaser et al., 2004; Simmons et al., 2003).
Furthermore, several cytokine knockout mice (e.g., interferon-g,
tumor necrosis factor-a, IL-6, and either p19 or IL-12p40)
have delayed clearance of C. rodentium infection (Dann et al.,
2008; Goncalves et al., 2001; Mangan et al., 2006; Simmons
et al., 2002).
We used the A/E pathogen, C. rodentium, to probe the func-
tional importance and cellular targets of GM-CSF in the intestinal
mucosa. We show that GM-CSF produced in the intestinal
mucosa in vivo acts in a nonredundant manner to enhance
host protection to an A/E pathogen through mechanisms that
involve DC and epithelial cells.& Microbe 7, 151–163, February 18, 2010 ª2010 Elsevier Inc. 151
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Figure 1. GM-CSF Induction in the Colon
of C. rodentium-Infected Mice
(A) Colon from B6 mice left uninfected or infected
withC. rodentium for 2 weeks was immunostained
with anti-GM-CSF antibody. Infected mice mani-
fest marked colonic crypt hyperplasia. Original
magnification, 3100.
(B) GM-CSF in colon tissue was determined by
ELISA at the indicated times after infection. Data
are mean ± SEM (n = 5 mice at each time point).
ND, none detected. *p < 0.05 versus uninfected
control.
(C) (Top row) Colon from B6 mice infected with
C. rodentium for 2 weeks was immunostained for
GM-CSF (left panel, red) and CD11c (middle panel,
green).Right panel is amerged imageof the left and
middle panels and also includes nuclear staining.
(Bottom row) Colon was stained for GM-CSF (left
panel, red) and F4/80 (middle panel, green). Right
panel is amerged image including nuclear staining.
Merged images were created using Adobe
Photoshop software. Arrows indicate GM-CSF-
producing cells. Original magnification,3400.
Cell Host & Microbe
GM-CSF and Dendritic Cells in Mucosal DefenseRESULTS
Colonic GM-CSF Induction after C. rodentium Infection
To probe the in vivo functions of GM-CSF in mucosal defense,
WT B6 mice were infected with the A/E pathogen, C. rodentium.
GM-CSF production after infection increased significantly in the
colon (Figures 1A and 1B), but not in spleen or mesenteric lymph
nodes (MLNs), nor were serumGM-CSF levels elevated (data not
shown). GM-CSF protein was primarily observed in CD11c+ DCs
and F4/80+ macrophages in the infected colon mucosa (Fig-
ure 1C). To validate that GM-CSF immunostaining reflected
GM-CSF production by lamina propria leukocytes, rather than
GM-CSF uptake by lamina propria leukocytes that might
express GM-CSF receptors, GM-CSF mRNA was assessed
in lamina propria leukocytes and epithelial cells isolated from
C. rodentium-infected (2 weeks) and uninfected mice. GM-CSF
mRNA expression was upregulated by 4- to 5-fold in lamina
propria leukocytes (p < 0.05, n = 3) but was not upregulated in
colon epithelial cells after infection. Furthermore, lamina propria
leukocytes had400-fold higher GM-CSF mRNA levels than did
colon epithelial cells. Thus, increasedmucosal GM-CSF produc-
tion after infection largely reflects de novo production by DCs
and F4/80+ cells in the lamina propria. Together, these findings
demonstrate that mucosal GM-CSF production is increased
after infection and suggest that the cytokine may have a role in
mucosal host defense to this pathogen.
Increased Susceptibility of GM-CSF/ Mice
to C. rodentium Infection
To test the importance of GM-CSF during C. rodentium infec-
tion, we employed gene-targeted mice deficient in GM-CSF.152 Cell Host & Microbe 7, 151–163, February 18, 2010 ª2010 Elsevier Inc.l
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early after infection (4 days), indicating
that GM-CSF/ mice had no apparent
defect in innate antibacterial defense.
Consistent with this conclusion, GM-CSF deficiency did not impact expression of the epithelia
cell-produced antimicrobial peptide mCRAMP (data no
shown), which is critical in early defense against C. rodentium
(Iimura et al., 2005). However, at 1 week after infection, GM-
CSF/ mice had significantly increased mucosal colonization
with C. rodentium compared to WT B6 controls (Figure 2A)
significantly greater fecal counts of C. rodentium (Figure 2B)
and significantly greater systemic infection in spleen and
MLN (Figure 2C). In parallel, GM-CSF/ mice had lost signifi-
cantly more body weight after 2 weeks than WT B6 mice
(97.8% ± 1.5% versus 103.2% ± 1.1% of preinfection weight
respectively; p < 0.05), underlining the overall clinical impac
of GM-CSF deficiency on the course of the infection. B6 mice
had cleared infection by 3 weeks, whereas clearance did no
occur until 4 weeks after infection in GM-CSF/ mice
(Figure 2B).
Serum titers of IgM and IgG anti-C. rodentium antibodies were
significantly lower in infected GM-CSF/ than in WT B6 mice
(Figure 2D). Further, after C. rodentium infection, GM-CSF/
mice had increased and more persistent colonic crypt hyper-
plasia (Figures 2E and 2F), significantly higher levels of mucosa
MPO (Figure 2G), and increased expression of the proinflamma-
tory cytokines TNF-a, KC, andMIP-2a (Figure 2H). No significan
differences betweenWT andGM-CSF/mice were found in the
expression of IFN-g, IL-12p40, IL-23p19, IL-10, IL-17, IL-6, IL-4
or IL-1b during the 3 weeks after infection (data not shown)
Taken together, these data indicate GM-CSF has an importan
role in controlling themagnitude of mucosal and systemic bacte-
rial infection, the mucosal proinflammatory cytokine response
and the adaptive immune response important for clearance o
C. rodentium.
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Infected GM-CSF/ Mice
To begin to define the mechanisms by which GM-CSF contrib-
utes to mucosal host defense, we examined mucosal DC
numbers, as DC precursors from BM in vitro are targets of
GM-CSF, and BM-derived DCs cultured in GM-CSF and IL-4
have an inflammatory phenotype possibly relevant to innate anti-
microbial host defense and inflammation in vivo (Serbina et al.,
2003; Xu et al., 2007). Uninfected WT B6 and B6 GM-CSF/
mice had similar numbers and distribution of CD11c+ DC in the
colon (Figures 3A and 3B), which is consistent with prior studies
suggesting that GM-CSF is not required for steady-state DC
maintenance in lymphoid organs (Kingston et al., 2009; Vremec
et al., 1997).
After C. rodentium infection of WT B6 mice, CD11c+ DCs
were markedly increased in the lamina propria surrounding
the colon crypts and in the area immediately underlying surface
epithelial cells (Figure 3A). In contrast, significantly fewer
CD11c+ DCs were present in the colon mucosa of infected
GM-CSF/ mice (Figures 3A and 3B). Despite the absolute
numeric difference, the relative proportions of the two major
lamina propria DC subpopulations (i.e., MHC class II+,
CD11c+, CD11b+, CD103; and MHC class II+, CD11c+,
CD11b+, CD103+) (Bogunovic et al., 2009), the expression of
key activation markers (CD40, CD80, CD86), and the expression
of the migration-associated chemokine receptors, CCR7 and
CCR6, on CD11c+ DC did not differ between infected WT B6
and GM-CSF/mice (Figures 3C and 3D). However, compared
to CD11c+ DC isolated from the colon of infected WT B6 mice,
those from GM-CSF/ mice manifested a significant decrease
in the uptake of FITC-dextran, suggesting an abnormality in
endocytotic activity (see Figure S1 available online). No signifi-
cant increase of CD11c+ DC was observed in the spleen or
MLNs after infection of WT B6 and GM-CSF/ mice
(Figure 3E).
In contrast to CD11c+ DC, F4/80+ macrophages and Gr-1+
leukocytes were markedly increased in the colon mucosa of
infected GM-CSF/ compared to WT B6 mice (Figures 3F
and 3G). These results indicate that GM-CSF has an important
role in determining the number and localization of CD11c+ DC
under inflammatory conditions, and the magnitude of the
inflammatory response in the colon during C. rodentium
infection.
GM-CSF Administration Rescues the Abnormal Host
Response in GM-CSF/ Mice
To exclude the possibility that GM-CSF deficiency had caused
irreversible developmental abnormalities in the colon, we admin-
istered mGM-CSF daily to C. rodentium-infected GM-CSF/
mice and examined the effects on DC numbers and mucosal
defense. GM-CSF treatment significantly increased CD11c+
DCs in the colon (Figure 4A) to levels approaching those seen
in infectedWTB6mice (see Figure 3B). Moreover, cytokine treat-
ment partially corrected the attenuated IgG anti-C. rodentium
antibody response of GM-CSF/ mice (Figure 4B) and signifi-
cantly decreased systemic C. rodentium infection in the MLN
and spleen (Figure 4C). Thus, the lack of DC in the mucosa of in-
fected GM-CSF/ mice was not due to a developmental DC
defect.Cell HostFunctional Importance of CD11c+ DCs in the Host
Response to C. rodentium
Because GM-CSF deficiency resulted in diminishedmucosal DC
numbers after infection, we reasoned that the DC loss may be
responsible for the compromise in host defense. To determine
the functional importance of CD11c+ DCs, CD11c+ DCs were
depleted immediately after C. rodentium infection using a
DT-mediated strategy (Abe et al., 2007; Berndt et al., 2007;
Jung et al., 2002; Zaft et al., 2005). We used BM chimeras gener-
ated by reconstituting irradiated WT B6 mice with CD11c-DTR
BM for these studies, as those mice tolerate repeated DT injec-
tions without adverse side effects (Varol et al., 2009; Zaft et al.,
2005). Repeated injections of C. rodentium-infected B6 DTR-
BM chimera mice every third day with DT over a 15 day period
significantly decreased CD11c+ DCs in the colon, spleen, and
MLN (Figures S2A and S2B). Compared to DT-injected WT B6
controls, DT-injected B6 DTR-BM chimera mice had more
severe colonic mucosal injury and inflammation characterized
by multiple deep mucosal ulcerations after infection (Figure 5A),
significantly higher levels of mucosal MPO (Figure 5B), increased
numbers ofC. rodentium in the feces and spleen (Figures 5C and
5D), and lower serum titers of anti-C. rodentium IgG antibody
(Figure 5E). This defective host response in DC-depleted mice
after C. rodentium infection resembled that in infected
GM-CSF/ mice (Figure 2). DT injection had no impact on
mucosal histology, MPO levels in the colon, the magnitude of
C. rodentium colonization (as assessed by fecal CFU), or IgG
anti-C. rodentium antibody titers after infection of control B6
BM chimera mice or WT B6 mice (Figures S2C–S2F).
GM-CSF Deficiency Results in Increased Apoptosis
of CD11c+ Cells in the Colon Mucosa of Infected Mice
To address mechanisms responsible for decreased numbers of
CD11c+ DCs in C. rodentium-infected GM-CSF/ compared to
WT B6 mice, we asked whether proliferation or survival of
mucosal DCs was influenced by GM-CSF deficiency. Infected
B6 andGM-CSF/mice did not differ significantly in the number
and distribution of proliferating cells, as shown by BrdU staining
of the intestinal mucosa (Figure 6A), with most proliferating cells
being epithelial cells. However, the numbers of apoptotic cells
were significantly increased in the colon of C. rodentium-in-
fected GM-CSF/ mice compared to B6 mice (Figure 6B).
Most TUNEL-positive cells in infected GM-CSF/ mice were
located in the lamina propria and not the epithelium (Figure 6C).
Colon sections analyzed for CD11c+ DCs by immunostaining
and TUNEL+ cells confirmed a significant increase in TUNEL-
positive DCs in infected GM-CSF/ mice (Figure 6D). Further,
the percentage of TUNEL+ DCs was significantly greater among
CD11c+ cells isolated from the lamina propria of 2-week-infected
GM-CSF/ compared to B6 mice (Figure 6E). Thus, GM-CSF
appeared to be more important for mucosal DC survival than
DC proliferation after C. rodentium infection.
GM-CSF-Dependent CCL22 Production by Intestinal
Epithelial Cells Determines CD11c+ DC Recruitment
and Localization
Chemokines have amajor role in DC recruitment and localization
in peripheral tissues. We tested the possibility that increased
GM-CSF in the colon of infected mice regulated the expression& Microbe 7, 151–163, February 18, 2010 ª2010 Elsevier Inc. 153
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Figure 2. C. rodentium Infection in B6 and GM-CSF/ Mice
(A) One week after C. rodentium infection, colon sections from B6 andGM-CSF/mice were costained forC. rodentium (red) and F-actin (green). Colocalization
of C. rodentium and F-actin is shown in yellow. Original magnification, 3100.
(B) Fecal counts (CFU) of C. rodentium were determined at the indicated times after oral gavage of 5 3 108 C. rodentium to B6 and GM-CSF/mice. Data are
mean ± SEM of three independent experiments (n = 10–17 mice for each data point). Dotted line indicates detection limit of the CFU assay.
(C) C. rodentium in spleen and MLN of B6 andGM-CSF/mice were determined 2 weeks after infection. Data are shown as CFU from individual mice, and bars
represent the geometric means (n = 15–16). Dotted line indicates the detection limit of the CFU assay.
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GM-CSF and Dendritic Cells in Mucosal Defenseof mucosal DC chemoattractants. The chemokine CCL22 (also
termedmacrophage-derived chemokine,MDC)was significantly
increased at themRNA and protein level in the colon ofC. roden-
tium-infectedWTB6 but not inGM-CSF/mice (Figures 7A and
7B). Moreover, CCL22 was mostly produced by colon epithelial
cells after infection (Figures 7C and 7D, Figure S3). In parallel,
CD11c+ DCs were prominently localized in regions immediately
beneath surface colon epithelial cells with upregulated epithelial
CCL22 expression in infected WT B6 mice (Figure 7E, see also
Figure 3A). By comparison, in uninfected B6 mice, which have
little if any CCL22 expression, DCswere few and localizedmainly
near the base of the crypts (see Figure 3A). The loss of CCL22
expression in the absence of GM-CSF was selective, since
expression of another epithelial cell-derived DC chemoattractant
chemokine, CCL20 (MIP-3a), was significantly increased in
GM-CSF/ compared to WT B6 mice after C. rodentium
infection (Figure 7A), whereas the DC chemoattractant, CCL8
(MCP-2), was expressed at similar levels in infected WT B6
and GM-CSF/ mice (Figure 7A).
To directly address the importance of CCL22 in DC recruit-
ment and localization during infection, C. rodentium-infected
B6 mice were injected with anti-CCL22 neutralizing antibody or
control IgG. The mucosa of CCL22 antibody-treated B6 mice
infected with C. rodentium lacked focal accumulations of DC in
the subepithelial regions underlying surface epithelial cells
(Figure 7F), and numbers of CD11c+ cells were significantly
decreased in the lamina propria, but not in the spleen or MLN
(Figure 7G). Consistent with this, at 2 weeks after infection,
a significant 5-fold increase in colon colonization with C. roden-
tium (p < 0.05, n = 3) was observed in B6 mice injected with anti-
CCL22 relative to those injected with isotype control antibody.
These results indicate a key role for GM-CSF, acting in concert
with CCL22, in the recruitment and retention of DCs in the
mucosa upon C. rodentium infection.DISCUSSION
A/E lesion-inducing enteric pathogens are significant causes of
diarrhea and life-threatening disease in humans. Like entero-
pathogenic and enterohemorrhagic E. coli in humans, themurine
A/E pathogen, C. rodentium, interacts with and signals via the
intestinal epithelium, but does not invade the mucosa of WT
mice to a significant degree, raising fundamental questions
about the nature of effective defense against minimally invasive
mucosal pathogens. We show here that GM-CSF produced in
the intestinal mucosa is an important mediator of host defense
against C. rodentium, since mice deficient in GM-CSF mani-
fested increased mucosal colonization with the bacteria, more(D) IgG and IgM serum antibodies toC. rodentium in B6 andGM-CSF/mice wer
of optical density (n = 10–15 mice time point).
(E) B6 and GM-CSF/mice were left uninfected or infected with C. rodentium fo
with H&E. Original magnification, 3100. Scale bar is 200 mm.
(F) Colonic crypt depth in C. rodentium-infected B6 and GM-CSF/ mice w
(n = 5–10 mice per group at each time point).
(G) MPO in colon tissue was assayed by ELISA. Data are mean ± SEM (n = 5–10
(H) TNF-a, KC, andMIP-2amRNA transcripts in colon tissue of B6 andGM-CSF/
per group at each time point). *p < 0.05 relative to B6 mice at indicated time poi
Cell Hostsevere and prolonged colonic mucosal inflammation, delayed
bacterial clearance, and increased systemic infection.
CD11c+ DCs, intestinal epithelial cells, and interactions
between products of those cells were key for GM-CSF-mediated
host defense. GM-CSF, alone and in combination with IL-4, stim-
ulates the generation of DCs from BM or peripheral blood mono-
nuclear cells in culture, but its physiological role in the generation
and survival of DCs in the intestinal mucosa in vivo and in host
protection from enteric pathogens was not known. We consid-
ered that decreased numbers of DCs in the mucosa of infected
GM-CSF/ mice might reflect a developmental defect or the
lack of differentiation of a population of DCs that populate the
colon lamina propria, as GM-CSF has been reported in two
recent studies to be variably important in the preferential devel-
opment/differentiation of the lamina propria CD11b+CD103+
DCs (Bogunovic et al., 2009) or alternatively CD11b+ but mainly
CD103 DCs (Varol et al., 2009). Alternatively, a defect might
exist in recruitment of themajor DC subpopulations to the lamina
propria. However, we found no evidence in support of those
possibilities in our infection model, since the proportion of the
predominant CD11b+CD103+ DCs relative to CD11b+CD103
cells in the lamina propria of infected WT B6 and GM-CSF/
mice did not differ significantly. We also detected no difference
between WT B6 and GM-CSF/mice in the relative number
of DCs expressing CCR7, a receptor which is preferentially
expressed on CD11b+CD103+ DC in the lamina propria (Bogu-
novic et al., 2009) and controls DC migration to draining lymph
nodes (Forster et al., 1999; Johansson-Lindbom et al., 2005;
Ohl et al., 2004). Moreover, supplementing GM-CSF-deficient
mice with GM-CSF restored DCs in the colon to levels approach-
ing those inWT B6mice, indicating GM-CSF deficiency does not
cause an irreversible developmental defect in DCs. Rather, we
show that GM-CSF is important for providing survival signals
to intestinal DCs, since their numbers and viability were
decreased after infection in the absence of GM-CSF, most likely
due to increased apoptosis. Consistent with CD11c+ DC having
a central role in GM-CSF-dependent mucosal defense, depletion
of CD11c+ DC in infected WT mice recapitulated the major
abnormalities in infected GM-CSF/ mice. These results
provide a paradigm for the role of GM-CSF during infection
with A/E pathogens, although we recognize that additional or
other mechanisms may come into play during infection with en-
teroinvasive pathogens that use different strategies for invasion
and evading host defense mechanisms.
We show that the C-C chemokine, CCL22, produced by intes-
tinal epithelial cells after infection in a GM-GSF-dependent
manner, has a major role in the recruitment of CD11c+ DCs
and their localization to the subepithelial region of surface
epithelial cells, as neutralization of CCL22 in WT mice abrogatede assayed by ELISA at the indicated times after infection. Data are mean ± SEM
r up to 4 weeks. Sections of colon obtained at the indicated times were stained
as assessed at the indicated times after infection. Data are mean ± SEM
mice per group at each time point).
micewere assayed by real-time RT-PCR. Data aremean ± SEM (n = 4–5mice
nts.
& Microbe 7, 151–163, February 18, 2010 ª2010 Elsevier Inc. 155
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provide an important physiological correlate to the in vitro obser-
vation that CCL22 is chemotactic for monocyte-derived and BM
DCs (Bonecchi et al., 1998; Vecchi et al., 1999). CCL22 also che-
moattracts CD4+ T cells, NK cells, and monocytes in vitro,
although we did not note decreases in these cells in GM-CSF-
deficient mice. Furthermore, the observed predominant epithe-
lial production of CCL22 is consistent with the reported inducible
production of the chemokine in human intestinal epithelial cell
lines (Berin et al., 2001). Other cell types, including monocyte-
derived DCs, macrophages, pro-B cells, and T cells (Godiska
et al., 1997; Mantovani et al., 2000), can produce CCL22, yet
we did not observe CCL22 production in those cells despite their
abundance in the intestinal mucosa after infection. In cultured
epithelial cell lines, IFN-g and TNF-a upregulate CCL22 produc-
tion (Berin et al., 2001), yet induction of these cytokines was
not impacted by GM-CSF deficiency, suggesting that in the
absence of GM-CSF those cytokines were not sufficient to
upregulate epithelial CCL22 production. However, whether
CCL22 production after infection in vivo is mediated by a direct
or indirect activity of GM-CSF on epithelial cells is not known.
In contrast to CCL22, another DC chemoattractant, CCL20,
important for DC infiltration and mucosal host defense during
parasitic infection with Trichuris muris (Cruickshank et al.,
2009), was not required for DC recruitment or localization in
C. rodentium-infected WT or GM-CSF/ mice (Y.H. and
M.F.K., unpublished data).
GM-CSF had a nonredundant role in host defense against
C. rodentium that affected several phases of the host response
to infection, including the extent of surface colonization, the
mucosal inflammatory response, and the later adaptive immune
response required for clearing infection. GM-CSF contrasts with
several other cytokines and antimicrobial peptides that can con-
tribute to mucosal defense to C. rodentium (Dann et al., 2008;
Goncalves et al., 2001; Iimura et al., 2005; Mundy et al., 2005;
Simmons et al., 2002; Spahn et al., 2004; Zheng et al., 2008).
For example, GM-CSF/ mice, but not mice deficient in IL-6
(Dann et al., 2008), had an increased burden of infection by 1
week (but not very early at 4 days) after infection and decreased
antibacterial antibodies essential for bacterial clearance (Maaser
et al., 2004). Despite markedly increased expression of IFN-g
and TNF-a, which play a role in bacterial clearance (Goncalves
et al., 2001; Simmons et al., 2002), mice deficient in GM-CSF/
mice had delayed clearance of the pathogen, indicating thatFigure 3. Decreased CD11c+ DC in C. rodentium-Infected GM-CSF/
(A) CD11c+ cells in the colon of B6 andGM-CSF/mice infected for 2 weeks wit
staining of F-actin is in green. Arrows indicate CD11c+ cells underlying surface e
3-week-infected mice.
(B) Flow cytometric analysis of cells isolated from the colon lamina propria of B
stained with PE-conjugated CD11c and FITC-conjugated I-Ab. Results of a repres
experiments.
(C) Flow cytometric analysis of CD11c+ DCs isolated from the colon of B6 and G
CD103 and FITC-conjugated CD11b. Results of a representative experiment are
(D) DCs were isolated from 2-week-infected colon as in (C), and surface marker e
the chemokine receptors CCR6 and CCR7 on DCs was assessed by flow cytom
(E) Spleen and MLN cells from B6 and GM-CSF/ mice obtained 2 weeks after
(F and G) C. rodentium-infected colon from B6 andGM-CSF/mice was stained
with Alexa-Fluoro 488 phalloidin (green). Original magnification, 3200.
Cell HostGM-CSF has unique immune defense functions that cannot be
compensated for by these two cytokines.
The intestinal mucosa of GM-CSF/ mice was histologically
normal in the absence of infection. However, the inflammatory
response in infected GM-CSF/ mice compared to WT mice
was markedly more severe and characterized by increased
expression of proinflammatory cytokines, neutrophil and mono-
cyte/macrophage chemoattractants, and an accompanying infil-
tration of F4/80+ macrophages and Gr-1+ neutrophils. Nonethe-
less, the increased inflammatory response did not compensate
for the indispensable host protective role mediated by GM-
CSF in the intestinal tract. GM-CSF also has important functions
in host defense against pulmonary infection with group B Strep-
tococcus, Pseudomonas aeruginosa, and Pneumocystis carinii
(Ballinger et al., 2006; LeVine et al., 1999; Paine et al., 2000).
However, in contrast to enteric infection with C. rodentium,
where CD11c+ DCs primarily mediate GM-CSF-dependent
host defense, the functions of GM-CSF in defense against those
pulmonary pathogens appear mainly dependent on the activity
of alveolar macrophages (Ballinger et al., 2006; LeVine et al.,
1999; Paine et al., 2000).
GM-CSF augments the survival of neutrophils and monocyte/
macrophage, and the production of proinflammatory chemo-
kines and mediators by these cells (Hamilton, 2008; Hamilton
andAnderson, 2004). Administration ofGM-CSF in vivo provokes
inflammation and exacerbates autoimmune diseases, such as
inflammatory arthritis and experimental autoimmuneencephalitis
(EAE) in mice and rheumatoid arthritis in humans (Bischof et al.,
2000; Campbell et al., 1997; Hamilton, 2008; Marusic et al.,
2002). Conversely, mice deficient in GM-CSF/ were protected
from collagen-induced arthritis (Campbell et al., 1998;McQualter
et al., 2001) and EAE. In Crohn’s disease, a chronic inflammatory
intestinal disease, two modes of therapy known to decrease
GM-CSFproduction, anti-TNF-a antibodies and glucocorticoids,
are widely used to attenuate inflammation. However, contrary
and counterintuitive to this, GM-CSF administration to Crohn’s
disease patients resulted in clinical improvement and less
mucosal inflammation (DieckgraefeandKorzenik, 2002;Korzenik
et al., 2005). The present data on host mucosal response to an
A/E pathogen may have relevance for understanding the
abnormal host response to the enteric microbial flora in
Crohn’s disease, which is thought to be a significant factor in
the pathogenesis of the disease and in mouse models of chronic
intestinal inflammation (Salzman and Bevins, 2008; Wirtz andMice
h C. rodentium or left uninfected. CD11c+ cells are shown in red, and phalloidin
pithelial cells. Original magnification, 3200. Similar results were obtained from
6 and GM-CSF/ mice 2 weeks after infection or left uninfected. Cells were
entative experiment are shown. Similar results were obtained in three repeated
M-CSF/ mice infected for 2 weeks. DCs were stained with PE-conjugated
shown. Similar results were obtained in two repeated experiments.
xpression of the activation markers CD40, CD80, CD86 and the expression of
etry.
infection were characterized as in (B).
2 weeks after infection for F4/80 (red, F) and Gr-1 (red, G). F-actin was stained
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Figure 4. Rescue of the Abnormal Pheno-
type in C. rodentium-Infected GM-CSF/
Mice by GM-CSF Administration
(A) GM-CSF/ mice infected with 5 3 108
C. rodentium were injected with PBS or GM-CSF
(5 mg/mouse) i.p. daily for 2 weeks, after which
lamina propria cells from the colon were isolated
and analyzed by flow cytometry as in Figure 2B.
Similar results were obtained in two repeated
experiments.
(B) IgG antibodies to C. rodentium from PBS
or GM-CSF-treated C. rodentium-infected GM-
CSF/ mice were assayed by ELISA. Data are
mean ± SEM (n = 12 mice per group).
(C) C. rodentium in the spleen and MLN of PBS or
GM-CSF-treated GM-CSF/ mice were deter-
mined by CFU assay 2 weeks after infection as in
Figure 2. Data are shown as CFU from individual
mice (n = 11), and the bar indicates the geometric
mean. Dotted line indicates the detection limit of
the CFU assay. *p < 0.05 relative to PBS-treated
mice at the indicated time points.
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GM-CSF and Dendritic Cells in Mucosal DefenseNeurath, 2007). Thus, our studies indirectly suggest thatDC func-
tions in response to microbial stimuli may be deficient in patients
with Crohn’s disease, perhaps explaining the increase in chronic
infiltration with acute and chronic inflammatory cells and the
beneficial effects of exogenous administration of GM-CSF in
this disease.
EXPERIMENTAL PROCEDURES
Mice
WT C57BL/6J (B6) mice and B6.FVB-Tg(Itgax-DTR/EGFP)57Lan/J mice were
from The Jackson Laboratory. GM-CSF/ mice, backcrossed for more than
ten generations to B6 mice, were provided by Dr. B. Trapnell (Cincinnati,B6 B6-tg-DTR
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158 Cell Host & Microbe 7, 151–163, February 18, 2010 ª2010 ElsevOH) and maintained at the University of California, San Diego (UCSD). All
animal studies were approved by the UCSD Institutional Animal Care and
Use Committee.
Bone Marrow Chimera Mice and Dendritic Cell Depletion
To generate BM chimeric mice, WT B6 recipients received a single lethal dose
of 9 Gy total body irradiation from a 137Cesium source. On the following day,
mice were injected i.v. with 2–5 3 106 BM cells from WT B6 or B6.FVB-Tg (It-
gax-DTR/EGFP)57Lan/Jmice (referred to hereafter as B6WT-BMchimera and
B6 DTR-BM chimera, respectively) (Zaft et al., 2005) and then rested for 8
weeks before use. For DC depletion, C. rodentium-infected WT B6, B6 WT-
BM chimera, and B6 DTR-BM chimera mice were injected i.p. with 100 ng
diphtheria toxin (Sigma-Aldrich) immediately after infection and every third
day thereafter during the 15 day experimental period.B6 B6-tg-
DTR
*
B6
B6-tg-DTR
e after infection (weeks)
1 2
*
*
Figure 5. C. rodentium-Induced Colitis in
CD11c+ DC-Depleted Mice
(A) H&E staining of the colon from 2-week-infected
B6 and B6 DTR-BM chimera mice treated with DT.
Original magnification,3100. Scale bar is 200 mm.
(B) MPO in colon tissue from 2-week-infected
mice treated with DT was quantified by ELISA.
Data are mean ± SEM (n = 10).
(C) Fecal CFUs of C. rodentium were determined
at 1 and 2 weeks after oral gavage of 5 3 108 C.
rodentium to B6 and B6 DTR-BM chimera mice
treated with DT. Data are mean ± SEM (n = 9
mice per group).
(D) C. rodentium CFU in the spleens of DT treated
mice were determined 2 weeks after infection.
Data are shown from individual mice. Bar repre-
sents the geometric mean (n = 9). Dotted line indi-
cates the detection limit of the CFU assay.
(E) Serum anti-C. rodentium IgG at the indicated
times after infection with C. rodentium in B6 and
B6 DTR-BM chimera mice treated with DT was
determined by ELISA. Data are mean ± SEM
(n = 5–10 mice for each group at each time point).
*p < 0.05 relative to B6 mice.
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Figure 6. DC Proliferation and Apoptosis in C. rodentium-Infected Mice
(A) BrdU staining (red) in colon sections of C. rodentium-infected (2 weeks) B6 and GM-CSF/ mice. Nuclei were stained with Hoechst 33258 (blue). Original
magnification, 3200.
(B) TUNEL staining (green, examples of apoptotic cells shown by arrows) of colon sections from 2-week-infected B6 and GM-CSF/ mice. F-actin (red) was
stained with Alexa Fluor 568-conjugated phalloidin. Original magnification, 3200.
(C) Colon sections from 2-week-infected GM-CSF/ mice. TUNEL staining (green), F-actin staining (red), nuclear staining (blue, Hoechst 33258 dye),
and merged image. Arrows indicate TUNEL-positive cells in the lamina propria, and arrowheads indicate TUNEL-positive epithelial cells, respectively. Original
magnification, 3200.
(D) Colon sections from 2-week-infected GM-CSF/ mice. TUNEL staining (green) and CD11c staining (red). Merged image and magnified image of the inset
(right panel) are also shown. Arrows indicate TUNEL and CD11c double positive cells. Original magnification 3200.
(E) TUNEL staining of CD11c+ DCs isolated from the colon of 2-week-infected B6 andGM-CSF/mice. The percentage of TUNEL-positive cells in three different
4003 visual fields of each cytospin slide was calculated and is shown as mean ± SD. Results of a representative experiment are shown. Similar results were
obtained in two repeated experiments. *p < 0.05 relative to B6 mice.
Cell Host & Microbe
GM-CSF and Dendritic Cells in Mucosal DefenseInfections and CFU Assays
C. rodentium was grown overnight in Luria-Bertani broth at 37C. Mice (8–
12 weeks) were infected with 5 3 108 C. rodentium by oral gavage (Eckmann,
2006; Maaser et al., 2004). This inoculum uniformly infected WT B6 mice, yet
was not lethal, with pathogen clearance occurring by 3 weeks postinfection.
Bacterial numbers in feces and homogenized tissues were determined by
plating serial dilutions onto MacConkey agar. Detection limit of the CFU assay
was 103 colonies per g of feces and 10 colonies per organ. Samples without
detectable C. rodentium colonies were assigned a log10 value equivalent to
half of the detection limit of the CFU assay (Maaser et al., 2004).
Antibodies and Reagents
The followingmonoclonal antibodies were used: rat anti-mouse F4/80 (biotiny-
lated-, and FITC-conjugated, IgG2b), rat anti-mouse GM-CSF (IgG2a), and ratCell Hostanti-mouse CCR7 (FITC-conjugated, IgG2b) from Serotec; rat anti-mouse
Gr-1 (biotinylated-, and FITC- conjugated, IgG2b), hamster anti-mouse CD11c
(biotinylated-, FITC-, and PE-conjugated, IgG1), and murine anti-mouse I-Ab
(FITC-conjugated, IgG2a) from BD Biosciences; hamster anti-mouse CD40
(FITC-conjugated, IgM), hamster anti-mouse CD80 (FITC-conjugated, IgG),
rat anti-mouse CD86 (FITC-conjugated, IgG2a), and rat anti-mouse CD16/32
(IgG2a) from eBiosciences; and rat anti-mouse CCR6 (FITC-conjugated,
IgG2a) and rat anti-mouse GM-CSF (IgG2a) from R&D Systems. The following
polyclonal antibodies were used: goat anti-mouse and rat CCL22 (IgG) from
Santa Cruz for immunostaining experiments, goat anti-mouse CCL22 (IgG)
from R&D Systems for in vivo neutralization experiments, and rabbit
anti-FITC (Alexa 488-conjugated, IgG) from Molecular Probes. Control goat
IgG was from R&D Systems. Pegylated mouse GM-CSF (mGM-CSF) was
provided by Dr. E. Croze, Bayer Healthcare.& Microbe 7, 151–163, February 18, 2010 ª2010 Elsevier Inc. 159
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Figure 7. GM-CSF Upregulates Epithelial Cell Expression of the DC Chemoattractant CCL22
(A) mRNA transcripts for the three DC chemoattractant chemokines, CCL22, CCL8, and CCL20, were assayed by real-time RT-PCR in the colon of B6 and
GM-CSF/ mice left uninfected or infected with C. rodentium. Data are mean ± SEM (n = 4–5 mice per group at each time point).
(B) CCL22 protein was assayed in colon extracts from B6 and GM-CSF/mice. Data are mean ± SEM (n = 5 mice per group at each time point). For (A) and (B),
*p < 0.05 relative to B6 mice at the indicated time points.
(C) Colon sections fromB6mice left uninfected and B6 andGM-CSF/mice infected for 3 weekswithC. rodentiumwere stained for CCL22 (red). Original magni-
fication, 3200.
(D) Colon sections from B6 mice infected for 3 weeks were stained for CCL22 (red) and b-catenin (green) as an epithelial cell marker. Nuclei were stained with
Hoechst 33258 (blue). Specificity controls using control antibody or anti-CCL22 absorbed with CCL22 peptide showed no immunostaining (see Figure S3).
(E) Colon sections from B6 mice infected for 3 weeks were stained for CCL22 (red) and CD11c (green). Original magnification, 3400.
(F) WT B6 mice were infected with C. rodentium for 2 weeks. On days 9, 11, and 13 after infection, mice were injected i.p. with 20 mg IgG goat anti-CCL22 or
control goat IgG. Colon sections from anti-CCL22 and control goat IgG-treated mice were stained for CD11c (red) and F-actin (green). Original magnification,
3200.
(G) Cells isolated from colon lamina propria, spleen, and MLN of anti-CCL22 and control goat IgG-treated mice were characterized by flow cytometry.
Similar results were obtained in two independent experiments.
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GM-CSF and Dendritic Cells in Mucosal DefenseHistologic Analysis and Immunohistochemistry
Colons were processed as Swiss rolls (Maaser et al., 2004). Tissues were fixed
in 10% formalin and embedded in paraffin, and 5 mm sections were stained
with hematoxylin and eosin (H&E). Colonic crypt depth was determined with
imaging software (PictureFrame, Optronics). Well-oriented crypts, at least
ten crypts apart, were measured throughout the distal colon. The three highest
values obtained were used to calculate maximal crypt depth (Maaser et al.,
2004).
For immunohistochemistry, tissues were frozen in OCT compound and 5 mm
sections were fixed in acetone for 5 min, washed, and blocked with PBS/2%
BSA, followed by avidin biotin blocking (Avidin Biotin blocking kit, DAKO).
Sections were incubated with primary antibody overnight. Antibodies and
dilutions used for immunohistochemistry are provided in the Supplemental
Experimental Procedures. For BrdU staining, mice were injected i.p. with
BrdU (1 mg) 2 hr before sacrifice, and colon tissues were stained using
a BrdU In Situ Staining Kit (BD Biosciences). TUNEL staining on colon tissue
and cytospin preparations used an ApoAlert DNA Fragmentation Kit (Clontech160 Cell Host & Microbe 7, 151–163, February 18, 2010 ª2010 ElsevLaboratories). Images from fluorescence microscopy were photographed
using imaging software (PictureFrame). Digital images were processed using
Adobe Photoshop 7.0 (Adobe Systems), with the same settings being applied
for test and control antibodies.
RT-PCR, ELISA, IgG, and IgM Anti-C. rodentium Antibody
Quantitative real-time RT-PCR was performed as described before (Hirata
et al., 2007) using primer sequences for TNF-a (Chae et al., 2006), MIP-2a,
(Iimura et al., 2005), IFN-g and IL-12 p40 (Wheeler et al., 2006), IL-1b (Schrop-
pel et al., 2005), IL-17 (Lubberts et al., 2005), GM-CSF (Sakai et al., 1999), KC,
CCL8, CCL20, and CCL22 (Lean et al., 2002). GM-CSF, CCL22 (R&D
Systems), and myeloperoxidase (MPO, Hycult Biotechnology) in supernatants
were determined by ELISA according to the manufacturers’ instructions.
Assay sensitivities were <10 pg/ml for GM-CSF and CCL22, and 1 ng/ml for
MPO. ELISA results were adjusted for tissue protein concentration determined
by Bradford assay (Bio-Rad). IgG and IgM anti-C. rodentium titers were deter-
mined as described in the Supplemental Experimental Procedures.ier Inc.
Cell Host & Microbe
GM-CSF and Dendritic Cells in Mucosal DefenseLeukocyte and DC Isolation from Colon Lamina Propria, Spleen,
and MLN Leukocytes
Leukocytes were isolated from the colon lamina propria, spleen, and MLN as
described in the Supplemental Experimental Procedures. For DC isolation
from lamina propria leukocytes, CD11c+ cells were enriched by positive
selection using MACS Microbeads (Miltenyi Biotec), according to the manu-
facturer’s instructions. Preparations contained >90% CD11c+ cells by flow
cytometry.
Flow Cytometry
Isolated cells were incubated with 0.5 mg of anti-mouse CD16/32 for 30 min at
4C to block Fc receptors. After blocking, surfacemarkerswere detected using
FITC- or PE- conjugated anti-CD11c, and anti-I-Ab with appropriate control
antibodies. For characterization of MACS-purified lamina propria DCs, FITC-
conjugated CD11b, CD40, CD86, CCR6, CCR7, and PE-conjugated CD103
with appropriate control antibodies were used. Samples were analyzed by
FACScan (BD Biosciences) using CellQuest software (BD Biosciences).
Endocytosis Assay
DCs isolated from colon tissues (13 105/sample) were incubated with 1mg/ml
FITC-dextran (40 kDa; Sigma) for 1 hr at 37C or at 4C (control). Cells were
washed three times in ice-cold PBS, 5% FBS, and analyzed by flow cytometry
for mean fluorescence intensity (MFI). Endocytic activity was expressed as
experimental MFI – control MFI.
Statistical Analysis
Differences between samples were evaluated with the Mann-Whitney rank
sum test or t test; p values <0.05 were considered significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and Supplemental Experi-
mental Procedures and can be found with this article online at doi:10.1016/
j.chom.2010.01.006.
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